Literature DB >> 16963085

Domain swapping in p13suc1 results in formation of native-like, cytotoxic aggregates.

Frederic Rousseau1, Hannah Wilkinson, Josep Villanueva, Luis Serrano, Joost W H Schymkowitz, Laura S Itzhaki.   

Abstract

The field of protein aggregation has been occupied mainly with the study of beta-strand self-association that occurs as a result of misfolding and leads to the formation of toxic protein aggregates and amyloid fibers. However, some of these aggregates retain native-like structural and enzymatic properties suggesting mechanisms other than beta-strand assembly. p13suc1 is a small protein that can exist as a monomer or a domain-swapped dimer. Here, we show that, under native conditions, p13suc1 forms three-dimensional domain-swapped aggregates, and that these aggregates are cytotoxic. Thus, toxicity of protein aggregates is not only associated with beta-rich assemblies and amyloid fibers, involving non-native interactions, but it can be induced by oligomeric misassembly that maintains predominantly native-like interactions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16963085     DOI: 10.1016/j.jmb.2006.07.061

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  10 in total

1.  Domain swapping and amyloid fibril conformation.

Authors:  Patrick C A van der Wel
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

2.  Synthetic lipid vesicles recruit native-like aggregates and affect the aggregation process of the prion Ure2p: insights on vesicle permeabilization and charge selectivity.

Authors:  Laura Pieri; Monica Bucciantini; Patrizio Guasti; Jimmy Savistchenko; Ronald Melki; Massimo Stefani
Journal:  Biophys J       Date:  2009-04-22       Impact factor: 4.033

3.  Understanding the relevance of local conformational stability and dynamics to the aggregation propensity of an IgG1 and IgG2 monoclonal antibodies.

Authors:  Santosh V Thakkar; Neha Sahni; Sangeeta B Joshi; Bruce A Kerwin; Feng He; David B Volkin; C Russell Middaugh
Journal:  Protein Sci       Date:  2013-08-19       Impact factor: 6.725

4.  Amyloid-like fibrils from a domain-swapping protein feature a parallel, in-register conformation without native-like interactions.

Authors:  Jun Li; Cody L Hoop; Ravindra Kodali; V N Sivanandam; Patrick C A van der Wel
Journal:  J Biol Chem       Date:  2011-06-28       Impact factor: 5.157

5.  Soluble oligomerization provides a beneficial fitness effect on destabilizing mutations.

Authors:  Shimon Bershtein; Wanmeng Mu; Wanmeng Wu; Eugene I Shakhnovich
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-12       Impact factor: 11.205

Review 6.  The βγ-crystallins: native state stability and pathways to aggregation.

Authors:  Eugene Serebryany; Jonathan A King
Journal:  Prog Biophys Mol Biol       Date:  2014-05-14       Impact factor: 3.667

7.  Prediction and Reduction of the Aggregation of Monoclonal Antibodies.

Authors:  Rob van der Kant; Anne R Karow-Zwick; Joost Van Durme; Michaela Blech; Rodrigo Gallardo; Daniel Seeliger; Kerstin Aßfalg; Pieter Baatsen; Griet Compernolle; Ann Gils; Joey M Studts; Patrick Schulz; Patrick Garidel; Joost Schymkowitz; Frederic Rousseau
Journal:  J Mol Biol       Date:  2017-03-18       Impact factor: 5.469

8.  Protein folding and misfolding on surfaces.

Authors:  Massimo Stefani
Journal:  Int J Mol Sci       Date:  2008-12-09       Impact factor: 6.208

Review 9.  Protein folding and aggregation into amyloid: the interference by natural phenolic compounds.

Authors:  Massimo Stefani; Stefania Rigacci
Journal:  Int J Mol Sci       Date:  2013-06-13       Impact factor: 5.923

10.  Electrostatic effects in the folding of the SH3 domain of the c-Src tyrosine kinase: pH-dependence in 3D-domain swapping and amyloid formation.

Authors:  Julio Bacarizo; Sergio Martinez-Rodriguez; Jose Manuel Martin-Garcia; Montserrat Andujar-Sanchez; Emilia Ortiz-Salmeron; Jose Luis Neira; Ana Camara-Artigas
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.